vorinostat has been researched along with Bilharziasis in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Excerpt | Relevance | Reference |
---|---|---|
"Schistosomiasis is a major neglected parasitic disease that affects more than 265 million people worldwide and for which the control strategy consists of mass treatment with the only available drug, praziquantel." | 4.02 | Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis. ( Darwish, S; Erdmann, F; Ghazy, E; Heimburg, T; Jung, M; Lancelot, J; Pierce, R; Robaa, D; Romier, C; Schmidt, M; Schmidtkunz, K; Shaik, TB; Simoben, CV; Sippl, W; Truhn, A; Zeyen, P, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ghazy, E | 1 |
Heimburg, T | 1 |
Lancelot, J | 1 |
Zeyen, P | 1 |
Schmidtkunz, K | 1 |
Truhn, A | 1 |
Darwish, S | 1 |
Simoben, CV | 1 |
Shaik, TB | 1 |
Erdmann, F | 1 |
Schmidt, M | 1 |
Robaa, D | 1 |
Romier, C | 1 |
Jung, M | 1 |
Pierce, R | 1 |
Sippl, W | 1 |
1 other study available for vorinostat and Bilharziasis
Article | Year |
---|---|
Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis.
Topics: Animals; Crystallography, X-Ray; Dose-Response Relationship, Drug; HEK293 Cells; Histone Deacetylase | 2021 |